Prospective Study of White Blood Cells
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorQuell Therapeutics Limited
About this trial
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- White blood cell and blood collection
Treatment groups
10 Participants
are divided into 1 treatment groupLocations
1Quell Investigator Site 01 London United Kingdom
Sponsors and collaborators
Quell Therapeutics Limited
Lead sponsor
Source ClinicalTrials.gov